Explore more publications!

Health Wire East Timor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire East Timor.

Press releases published on January 5, 2026

Alumis to Host Conference Call and Webcast to Report Phase 3 ONWARD Topline Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Teladoc Health to Participate in Upcoming Investor Conference
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Enovis Appoints Oliver Engert as Chief Administrative Officer
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
KALA BIO Settles Approximately $10.6 million of Debt
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference
The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference
AVITA Medical Announces Changes to its Board of Directors
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Citrus Burn Examined (URGENT REPORT) The Science Behind the Orange Peel Trick for Metabolic Support
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions